[8-K] InspireMD, Inc. Reports Material Event

Rhea-AI Filing Summary

InspireMD, Inc. filed an 8-K dated August 5, 2025 reporting that it issued a press release with financial and operating results for the three and six months ended June 30, 2025 (Item 2.02) and made an updated investor presentation available (Item 7.01).

The filing states the press release is attached as Exhibit 99.1 and the investor presentation as Exhibit 99.2, and that both are furnished (not "filed") under General Instruction B.2. The presentation is available on the company website at https://www.inspiremd.com/en/investors/. This 8-K does not include the underlying financial figures; readers must consult the attached exhibits for results.

Positive

• Timely disclosure of press release and updated investor presentation on August 5, 2025
• Exhibits attached (Exhibit 99.1 press release; Exhibit 99.2 investor presentation) for investor review
• Presentation available on the company investor website for direct access

Negative

• No financial figures or operating metrics are included in the 8-K body; details require consulting Exhibit 99.1
• Information furnished, not filed, which limits Section 18 liability and may affect incorporation by reference into other filings

Insights

Financial Analyst

TL;DR: Routine 8-K furnishing results press release and updated deck; no figures included here, review exhibits for material detail.

The filing serves primarily to notify investors that a press release on Q2 and six-month results and an updated investor presentation were furnished on August 5, 2025. As the 8-K itself contains no financial metrics, its direct informational value is limited until Exhibit 99.1 is reviewed. The "furnished, not filed" status preserves Section 18 liability limitations; analysts should retrieve the press release and deck for quantitative assessment.

Corporate Governance Expert

TL;DR: Disclosure is procedurally appropriate and timely, but material content resides in exhibits rather than the 8-K body.

The report follows standard practice by furnishing an earnings-related press release and an investor presentation and by citing General Instruction B.2 to limit Section 18 liability. From a governance and compliance perspective, the company met disclosure obligations. Investors should note the distinction between "furnished" and "filed" when considering incorporation by reference into future registration statements.

false 0001433607 0001433607 2025-08-05 2025-08-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): August 5, 2025

InspireMD, Inc.

(Exact Name of Registrant as Specified in Its Charter)

Delaware

(State or Other Jurisdiction of Incorporation)

001-35731		26-2123838
(Commission File Number)		(IRS Employer Identification No.)

6303 Waterford District Drive, Suite 215 Miami, Florida		33126
(Address of Principal Executive Offices)		(Zip Code)

(888) 776-6804

(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		NSPR		The Nasdaq Capital Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition

On August 5, 2025, InspireMD, Inc. (the “Company”) issued a press release announcing its financial and operating results and recent highlights for the three and six months ended June 30, 2025. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K that is furnished pursuant to this Item 2.02 shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 7.01 Regulation FD Disclosure.

On August 5, 2025, the Company made available an updated investor presentation. A copy of the presentation is attached hereto as Exhibit 99.2 and incorporated by reference in this Item 7.01. A copy of the presentation is also available on the Company’s website https://www.inspiremd.com/en/investors/.

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K that is furnished pursuant to this Item 7.01 shall not be deemed to be “filed” for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit Number		Description
99.1		Press release, dated August 5, 2025 (furnished herewith pursuant to Item 2.02)
99.2		Investor Presentation August 2025 (furnished herewith pursuant to Item 7.01)
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	INSPIREMD, INC.
Date: August 5, 2025	By:	/s/ Michael Lawless
	Name:	Michael Lawless
	Title:	Chief Financial Officer

FAQ

When did InspireMD (NSPR) file this 8-K?

The 8-K was filed on August 5, 2025.

What does Item 2.02 disclose in this 8-K for NSPR?

Item 2.02 states the company issued a press release announcing financial and operating results for the three and six months ended June 30, 2025, attached as Exhibit 99.1.

Is there an investor presentation included with the filing?

Yes. An updated investor presentation is furnished as Exhibit 99.2 and is available on the company website at https://www.inspiremd.com/en/investors/.

Does the 8-K itself provide the financial results for Q2 2025?

No. The 8-K references a press release with results but does not include the financial figures in the 8-K text; consult Exhibit 99.1.

What is the significance of the disclosure being "furnished" and not "filed"?

The filing cites General Instruction B.2, meaning the furnished materials are not subject to Section 18 liability and are not automatically incorporated by reference into other registration statements.